Breaking News
Start for Free 0
🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREE
Watch Now
Close

Nippon India Pharma Fund - Direct Plan - Growth Plan (0P0000XVFK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
563.699 -5.940    -1.04%
11/11 - Closed. Currency in INR
  • Morningstar Rating:
  • Total Assets: 86.89B
Type:  Fund
Market:  India
Issuer:  Reliance Nippon Life Asset Management Ltd
ISIN:  INF204K01I50 
Asset Class:  Equity
Reliance Pharma Fund - Direct Plan - Growth Plan 563.699 -5.940 -1.04%

0P0000XVFK Technical Analysis

 
A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Nippon India Pharma Fund - Direct Plan - Growth Plan fund. Access detailed technical analysis through moving averages buy/sell signals (simple and exponential for 5,10,20,50,100 and 200 periods) and common chart indicators (RSI, Stochastics, StochRSI, MACD, ADX, CCI, ROC, Williams %R, Ultimate and more) Buy, Sell, Overbought, Oversold or Neutral signals. Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All 0P0000XVFK fund Technical Studies are available in different time frames.
Summary:Strong Sell
Moving Averages:SellBuy (4)Sell (8)
Technical Indicators:Strong SellBuy (1)Sell (6)

Pivot PointsNov 11, 2024 22:15 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 569.637 569.637 569.637 569.637 569.637 569.637 569.637
Fibonacci 569.637 569.637 569.637 569.637 569.637 569.637 569.637
Camarilla 569.637 569.637 569.637 569.637 569.637 569.637 569.637
Woodie's 569.637 569.637 569.637 569.637 569.637 569.637 569.637
DeMark's - - 569.637 569.637 569.637 - -

Technical IndicatorsNov 11, 2024 22:15 GMT

Name Value Action
RSI(14) 44.155 Sell
STOCH(9,6) 63.371 Buy
STOCHRSI(14) 48.109 Neutral
MACD(12,26) -1.531 Sell
ADX(14) 100.000 Overbought
Williams %R -68.962 Sell
CCI(14) -41.6752 Neutral
ATR(14) 3.9913 Less Volatility
Highs/Lows(14) -1.4108 Sell
Ultimate Oscillator 49.395 Neutral
ROC -1.790 Sell
Bull/Bear Power(13) -9.0361 Sell

Buy: 1

Sell: 6

Neutral: 3


Summary:Strong Sell

Moving AveragesNov 11, 2024 22:15 GMT

Period Simple Exponential
MA5 568.427
Sell
566.950
Sell
MA10 566.434
Sell
567.852
Sell
MA20 569.707
Sell
568.884
Sell
MA50 573.598
Sell
565.259
Sell
MA100 549.419
Buy
549.640
Buy
MA200 510.634
Buy
511.496
Buy

Buy: 4

Sell: 8


Summary:Sell

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XVFK Comments

Write your thoughts about Nippon India Pharma Fund - Direct Plan - Growth Plan
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email